Company
IN8bio
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
(NASDAQ: INAB) is a clinical-stage immune-oncology company focused on delivering a novel off-the-shelf cell therapy for the treatment of cancer.
Loading relationship preview